0 followers
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Darrin M. Disley
This company has no offices yet
Queen Mary University
5 followers
Triyam
3 followers
The Health Foundation
1 follower
Mercedes Scientific
4 followers
Wellcome Sanger Institute
1 follower
MedPro Systems
1 follower
Search Laboratory
2 followers
Semble
4 followers
Stemline Therapeutics
3 followers
ICEO - Venture Builder
1 follower
Pfizer
516 followers
Explore companies